TherapeuticsMD (TXMD) Insider Trading & Ownership $1.78 0.00 (0.00%) As of 10:52 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings TherapeuticsMD (NASDAQ:TXMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$14.03KNumber OfInsiders Selling(Last 12 Months)0 Get TXMD Insider Trade Alerts Want to know when executives and insiders are buying or selling TherapeuticsMD stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TXMD Insider Buying and Selling by Quarter TherapeuticsMD Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type 10/28/2025 - 10/28/2026 Transaction Date Transaction Date From Transaction Date To 1M3M6MYTD1Y2Y3Y More filters Fewer filters Done 0 Results Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2025Tommy G ThompsonDirectorBuy8,400$1.67$14,028.00 (Data available from 1/1/2013 forward) TXMD Insider Trading Activity - Frequently Asked Questions Who is on TherapeuticsMD's Insider Roster? The list of insiders at TherapeuticsMD includes Cooper C Collins, Marlan D Walker, and Tommy G Thompson. Learn more on insiders at TXMD. What percentage of TherapeuticsMD stock is owned by insiders? 1.70% of TherapeuticsMD stock is owned by insiders. Learn more on TXMD's insider holdings. Which TherapeuticsMD insiders have been buying company stock? The following insiders have purchased TXMD shares in the last 24 months: Marlan D Walker ($1,478.32), and Tommy G Thompson ($14,353.00). How much insider buying is happening at TherapeuticsMD? Insiders have purchased a total of 10,351 TXMD shares in the last 24 months for a total of $15,831.32 bought. TherapeuticsMD Active InsidersRobert G Finizio (Age 55)CEOJames DareccaCFOMichael C. Donegan (Age 58)CAOPaul BisaroDirectorTommy G. ThompsonDirectorCooper C CollinsDirectorMarlan D. Walker (Age 50)General CounselEdward Borkowski (Age 66)EVP More Insider Trading Tools from MarketBeat Related Companies Aardvark Therapeutics Insider Trades Cognition Therapeutics Insider Trades MediciNova Insider Trades Heron Therapeutics Insider Trades Rafael Insider Trades Spero Therapeutics Insider Trades Cingulate Insider Trades Fortress Biotech Insider Trades Verrica Pharmaceuticals Insider Trades Tenax Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles Off-Price, High-Yield: Why Ross Stores Is Defying the Retail SlumpIntel's $155 Price Target Raises a Bigger Question About Its Turnaround PotentialInsiders Are Selling These 5 AI Stocks—Should You Worry?Intercepting Growth: Karman Secures $218M Lockheed Martin DealBoarding Now—GE Aerospace's Earnings Beat Comes With a Catch Insider trading data for NASDAQ:TXMD was last updated on 12/23/2025, the date of the most recent reported insider or congressional trade. New trades are added as they're reported. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredAnd they say the headline number understates what’s really happening.Goldman Sachs just admitted it underestimated central bank gold purchases by more than 500 percent, with buyin...Cedar Gold Group | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
